ArticleJournal of Korean medical science2025

Long-Term Safety of Tofacitinib for Treatment of Moderate-to-Severe Ulcerative Colitis: Three Years of Korean National Data.

Eun Mi Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.